KRT23: A Potential Drug Target for Various Diseases (G25984)

Target Name: KRT23

NCBI ID: G25984

KRT23

KRT23: A Potential Drug Target for Various Diseases

KRT23 (keratin 23, type I) is a protein that is expressed in a variety of tissues throughout the body, including hair, nails, and skin. It is a key component of the cytoskeleton, which is the structure that gives cells their shape and helps them maintain their integrity.

Recent studies have identified KRT23 as a potential drug target for the treatment of various diseases, including cancer, skin diseases, and autoimmune disorders. This is because KRT23 has been shown to play a role in the development and progression of these conditions.

One of the reasons why KRT23 has been identified as a potential drug target is because it is involved in the development of cancer. Many studies have shown that KRT23 is highly expressed in cancer cells, and that it is involved in the development of various types of cancer, including breast, lung, and ovarian cancer.

In addition, KRT23 has also been shown to be involved in the development of skin diseases. For example, studies have shown that KRT23 is highly expressed in skin samples from people with acne, and that it is involved in the development of this condition.

Another potential drug target for KRT23 is its role in autoimmune disorders. Many autoimmune disorders, such as rheumatoid arthritis and psoriasis, involve the immune system attacking the body's own tissues. KRT23 has been shown to be involved in the development and progression of these conditions, and it is thought to play a role in the immune response.

In conclusion, KRT23 is a protein that has been identified as a potential drug target for the treatment of various diseases. Its role in the development and progression of cancer, skin diseases, and autoimmune disorders makes it a promising target for future research and development.

Protein Name: Keratin 23

The "KRT23 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRT23 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets